Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tyrosine supplementation for phenylketonuria.

V J Poustie1, P Rutherford

  • 1Evidence Based Child Health Unit, Institute of Child Health, Royal Liverpool Children's Hospital NHS Trust, Alder Hey, Eaton Road, Liverpool, Merseyside, UK, L12 2AP. v.poustie@liv.ac.uk

The Cochrane Database of Systematic Reviews
|May 5, 2000
PubMed
Summary

Tyrosine supplementation in phenylketonuria (PKU) significantly increased blood tyrosine levels but did not improve other outcomes. More research is needed to determine if tyrosine supplements are beneficial for PKU patients on restricted diets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[High burden of disease in patients with ANCA-associated vasculitis : A claims data study in Germany].

Der Internist·2021
Same author

Working together to deliver stratified medicine research effectively.

British medical bulletin·2019
Same author

Low-dose aspirin for in vitro fertilisation.

The Cochrane database of systematic reviews·2007
Same author

Protein substitute for children and adults with phenylketonuria.

The Cochrane database of systematic reviews·2005
Same author

Reliability of calculating body mass index centile.

European journal of clinical nutrition·2005
Same author

Effect of introducing the Modified Early Warning score on clinical outcomes, cardio-pulmonary arrests and intensive care utilisation in acute medical admissions.

Anaesthesia·2003

Area of Science:

  • Biochemistry and Genetics
  • Metabolic Disorders
  • Nutritional Science

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder requiring strict phenylalanine restriction.
  • The PKU diet is challenging and may lead to tyrosine deficiency, potentially causing neuropsychological issues.
  • Tyrosine supplementation is explored as a way to mitigate these complications.

Purpose of the Study:

  • To evaluate the efficacy of tyrosine supplementation in PKU patients.
  • To assess its impact on intelligence, neuropsychological performance, growth, nutritional status, mortality, and quality of life.
  • To determine benefits alongside or as an alternative to phenylalanine-restricted diets.

Main Methods:

  • Systematic review of randomized or pseudo-randomized controlled trials.

Related Experiment Videos

  • Searched specialized trial registers and relevant journals up to November 1999.
  • Included trials comparing tyrosine supplementation versus placebo in PKU patients, excluding maternal PKU.

    • Main Results:

    • Two trials with 47 patients were analyzed.
    • Tyrosine supplementation significantly increased blood tyrosine concentrations compared to placebo.
    • No significant differences were observed in other measured outcomes.

    Conclusions:

    • Current evidence is insufficient to recommend routine tyrosine supplementation for PKU.
    • Further randomized controlled studies are necessary to establish its clinical utility.
    • The role of tyrosine supplementation in PKU management remains uncertain.